AssetMark Inc’s Juno Therapeutics, Inc. JUNO Stock Holding History

AssetMark Inc’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-19	Closed	-$1K	–	2267
2017 Q4	$1K	Buy	+19	New	+$948	﹤0.01%	1827
2016 Q1	–	Sell	-19	Closed	-$1K	–	1522
2015 Q4	$1K	Buy	+19	New	+$942	﹤0.01%	1335

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

AssetMark Inc's JUNO Position: Q1 2018 in Review

AssetMark Inc sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 19 shares — an estimated $1K sold.

AssetMark Inc first reported a position in JUNO in Q4 2015 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

AssetMark Inc reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
AssetMark Inc sold 19 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1K.
AssetMark Inc first reported a position in Juno Therapeutics, Inc. in Q4 2015 and held it in 2 quarters.
AssetMark Inc's Juno Therapeutics, Inc. position peaked at $1K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on AssetMark Inc's 13F filing for Q1 2018, filed 16 May 2018.